Indication: Matulane is indicated for use in combination with other anticancer drugs for the treatment of Stage III and IV Hodgkin’s disease. Matulane is used as part of the MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) regimen.

Important Safety Instruction

Please see full Prescribing Information for Matulane indications and usage, contraindications, and warnings including boxed WARNINGS, precautions, and adverse reactions.

Effective July 31, 2014, Matulane® (procarbazine hydrochloride) capsules (NDC 54482-053-01) will be distributed by Walgreen Co. As of 5pm on July 30, 2014 Accredo can no longer distribute Matulane. Click here for information to how to obtain the product.